Identification of a LNCaP-specific binding peptide using phage display

Pharmaceutical Research

Volumn 28, Issue 10, 2011, Pages 2422-2434

  Qin, Bin ^a   Tai, Wanyi ^a   Shukla, Ravi S ^a   Cheng, Kun ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

LNCaP; peptide ligand; phage display; prostate cancer; siRNA

Indexed keywords

ANTINEOPLASTIC AGENT; BINDING PROTEIN; FLUORESCEIN; HYBRID PROTEIN; LYSYLLEUCYLALANINE; LYSYLTYROSYLLEUCINE; PEPTIDE; PROAPOPTOTIC PEPTIDE; PROTAMINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL ASSAY; CELL DEATH; CELL LABELING; CELL SPECIFICITY; CELL STRAIN LNCAP; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN SYNTHESIS;

ANIMALS; BACTERIOPHAGES; CELL DEATH; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; NEOPLASM PROTEINS; PEPTIDE LIBRARY; PEPTIDES; PROSTATIC NEOPLASMS; PROTAMINES; PROTEIN BINDING; RATS; RNA, SMALL INTERFERING;

EID: 80054742840     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0469-7     Document Type: Article

References (40)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66 17237035 10.3322/canjclin.57.1.43 (Pubitemid 46148091)
2. NJ Mabjeesh H Zhong JW Simons 2002 Gene therapy of prostate cancer: current and future directions Endocr-Relat Cancer 9 115 139 12121835 10.1677/erc.0.0090115 1:CAS:528:DC%2BD38XntVeqs70%3D (Pubitemid 34832164)
3. Tai W, Mahato R, Cheng K. The role of HER2 in cancer therapy and targeted drug delivery. J Control Release 146:264-75.
4. DK Chang CT Lin CH Wu HC Wu 2009 A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer PLoS ONE 4 e4171 19137069 10.1371/journal.pone.0004171
5. Y Yoneda SC Steiniger K Capkova JM Mee Y Liu GF Kaufmann KD Janda 2008 A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy Bioorg Med Chem Lett 18 1632 1636 18243696 10.1016/j.bmcl.2008.01.060 1:CAS:528:DC%2BD1cXjt1Ckt7c%3D (Pubitemid 351318249)
6. G Cesarone OP Edupuganti CP Chen E Wickstrom 2007 Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1 Bioconjug Chem 18 1831 1840 17922544 10.1021/bc070135v 1:CAS:528:DC%2BD2sXhtFegs7%2FF (Pubitemid 350219981)
7. SL Deutscher SD Figueroa SR Kumar 2009 In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomas J Labelled Comp Radiopharm 52 583 590 20976123 1:CAS:528:DC%2BD1MXhsF2is7%2FE
8. Lee S, Xie J, Chen X. Peptide-based probes for targeted molecular imaging. Biochemistry 49:1364-76.
9. S Aggarwal P Singh O Topaloglu JT Isaacs SR Denmeade 2006 A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity Cancer Res 66 9171 9177 16982760 10.1158/0008-5472.CAN-06-1520 1:CAS:528:DC%2BD28Xps1aiu7w%3D (Pubitemid 44521137)
10. MA Burg R Pasqualini W Arap E Ruoslahti WB Stallcup 1999 NG2 proteoglycan-binding peptides target tumor neovasculature Cancer Res 59 2869 2874 10383148 1:CAS:528:DyaK1MXktVOru7w%3D (Pubitemid 29283125)
11. W Yang D Luo S Wang R Wang R Chen Y Liu T Zhu X Ma R Liu G Xu L Meng Y Lu J Zhou D Ma 2008 TMTP1, a novel tumor-homing peptide specifically targeting metastasis Clin Cancer Res 14 5494 5502 18765541 10.1158/1078-0432.CCR-08-0233 1:CAS:528:DC%2BD1cXhtVKmsbnN
12. C Wu SL Lo J Boulaire ML Hong HM Beh DS Leung S Wang 2008 A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro J Control Release 130 140 145 18632177 10.1016/j.jconrel.2008.05.015 1:CAS:528:DC%2BD1cXhtVais7rN
13. Y Kim AM Lillo SC Steiniger Y Liu C Ballatore A Anichini R Mortarini GF Kaufmann B Zhou B Felding-Habermann KD Janda 2006 Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand Biochemistry 45 9434 9444 16878978 10.1021/bi060264j 1:CAS:528:DC%2BD28XmtlOlsrw%3D (Pubitemid 44223248)
14. S Jager A Jahnke T Wilmes S Adebahr FN Vogtle E Delima-Hahn D Pfeifer T Berg M Lubbert M Trepel 2007 Leukemia-targeting ligands isolated from phage-display peptide libraries Leukemia 21 411 420 17252013 10.1038/sj.leu.2404548 1:STN:280:DC%2BD2s7htFWrtQ%3D%3D
15. S Nishimura S Takahashi H Kamikatahira Y Kuroki DE Jaalouk S O'Brien E Koivunen W Arap R Pasqualini H Nakayama A Kuniyasu 2008 Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells J Biol Chem 283 11752 11762 18292083 10.1074/jbc.M708849200 1:CAS:528:DC%2BD1cXkvVSgurs%3D
16. JA Joyce P Laakkonen M Bernasconi G Bergers E Ruoslahti D Hanahan 2003 Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis Cancer Cell 4 393 403 14667506 10.1016/S1535-6108(03)00271-X 1:CAS:528:DC%2BD3sXps1Ojtro%3D (Pubitemid 37491100)
17. JR Newton KA Kelly U Mahmood R Weissleder SL Deutscher 2006 In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice Neoplasia 8 772 780 16984734 10.1593/neo.06331 1:CAS:528:DC%2BD28XhtVGltbbN (Pubitemid 44465528)
18. GS Shuklaand DN Krag 2005 Phage display selection for cell-specific ligands: development of a screening procedure suitable for small tumor specimens J Drug Target 13 7 18 10.1080/10611860400020464 (Pubitemid 40309457)
19. GP Smithand VA Petrenko 1997 Phage display Chem Rev. 97 391 410 10.1021/cr960065d (Pubitemid 127659250)
20. SC Pero GS Shukla AL Armstrong D Peterson SP Fuller K Godin SL Kingsley-Richards DL Weaver J Bond DN Krag 2004 Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells Int J Cancer 111 951 960 15300809 10.1002/ijc.20306 1:CAS:528:DC%2BD2cXntVantL4%3D (Pubitemid 39096246)
21. NG Karasseva VV Glinsky NX Chen R Komatireddy TP Quinn 2002 Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library J Protein Chem 21 287 296 12168699 10.1023/A:1019749504418 1:CAS:528:DC%2BD38XmtVWrs7o%3D (Pubitemid 34839925)
22. RE Sobeland MD Sadar 2005 Cell lines used in prostate cancer research: a compendium of old and new lines-part 2 J Urol 173 360 372 10.1097/01.ju. 0000149989.01263.dc
23. RE Sobeland MD Sadar 2005 Cell lines used in prostate cancer research: a compendium of old and new lines-part 1 J Urol 173 342 359 10.1097/01.ju. 0000141580.30910.57
24. RS Israeli CT Powell JG Corr WR Fair WD Heston 1994 Expression of the prostate-specific membrane antigen Cancer Res 54 1807 1811 7511053 1:CAS:528:DyaK2cXisVWnurk%3D (Pubitemid 24116191)
25. RJ Giordano M Cardo-Vila J Lahdenranta R Pasqualini W Arap 2001 Biopanning and rapid analysis of selective interactive ligands Nat Med 7 1249 1253 11689892 10.1038/nm1101-1249 1:CAS:528:DC%2BD3MXotlOru7g%3D (Pubitemid 33063782)
26. S Liang T Lin J Ding Y Pan D Dang C Guo M Zhi P Zhao L Sun L Hong Y Shi L Yao J Liu K Wu D Fan 2006 Screening and identification of vascular-endothelial- cell-specific binding peptide in gastric cancer J Mol Med 84 764 773 16763842 10.1007/s00109-006-0064-2 1:CAS:528:DC%2BD28XptVajsrs%3D (Pubitemid 44334966)
27. RE Bruccoleri E Haber J Novotny 1988 Structure of antibody hypervariable loops reproduced by a conformational search algorithm Nature 335 564 568 3419534 10.1038/335564a0 1:CAS:528:DyaL1cXmtV2gtLs%3D
28. JC Mai Z Mi SH Kim B Ng PD Robbins 2001 A proapoptotic peptide for the treatment of solid tumors Cancer Res 61 7709 7712 11691780 1:CAS:528: DC%2BD3MXotlaktb8%3D (Pubitemid 33049352)
29. MA Arap J Lahdenranta PJ Mintz A Hajitou AS Sarkis W Arap R Pasqualini 2004 Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands Cancer Cell 6 275 284 15380518 10.1016/j.ccr.2004.08.018 1:CAS:528:DC%2BD2cXot1Kis7c%3D (Pubitemid 39222040)
30. E Bruckheimer P Harvie J Orthel B Dutzar K Furstoss E Mebel P Anklesaria R Paul 2004 In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma Cancer Gene Ther 11 128 134 14671672 10.1038/sj.cgt.7700662 1:CAS:528:DC%2BD2cXkt1yksw%3D%3D (Pubitemid 38141775)
31. JS Zhang S Li L Huang 2003 Cationic liposome-protamine-DNA complexes for gene delivery Meth Enzymol 373 332 342 14714413 10.1016/S0076-6879(03)73021-3 1:CAS:528:DC%2BD2cXhvFaqsLc%3D (Pubitemid 41103292)
32. E Song P Zhu SK Lee D Chowdhury S Kussman DM Dykxhoorn Y Feng D Palliser DB Weiner P Shankar WA Marasco J Lieberman 2005 Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat Biotechnol 23 709 717 15908939 10.1038/nbt1101 1:CAS:528:DC%2BD2MXkvVShs70%3D (Pubitemid 41716361)
33. N Dinauer D Lochmann I Demirhan A Bouazzaoui A Zimmer A Chandra J Kreuter H von Briesen 2004 Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation J Control Release 96 497 507 15120905 10.1016/j.jconrel.2004.02. 020 1:CAS:528:DC%2BD2cXjsFOltb0%3D (Pubitemid 38553927)
34. B Mannervik K Axelsson AC Sundewall A Holmgren 1983 Relative contributions of thioltransferase-and thioredoxin-dependent systems in reduction of low-molecular-mass and protein disulphides Biochem J 213 519 523 6351844 1:CAS:528:DyaL3sXltVWntrw%3D
35. DA Silver I Pellicer WR Fair WD Heston C Cordon-Cardo 1997 Prostate-specific membrane antigen expression in normal and malignant human tissues Clin Cancer Res 3 81 85 9815541 1:STN:280:DyaK1M%2FjsFamtA%3D%3D (Pubitemid 27079448)
36. JO McNamara 2nd ER Andrechek Y Wang KD Viles RE Rempel E Gilboa BA Sullenger PH Giangrande 2006 Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras Nat Biotechnol 24 1005 1015 16823371 10.1038/nbt1223 1:CAS:528:DC%2BD28XnvVygt7o%3D (Pubitemid 44215395)
37. MG Dozmorov RE Hurst DJ Culkin BP Kropp MB Frank J Osban TM Penning HK Lin 2009 Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells Prostate 69 1077 1090 19343732 10.1002/pros.20960 1:CAS:528:DC%2BD1MXos1Wiurw%3D
38. HM Ellerby W Arap LM Ellerby R Kain R Andrusiak GD Rio S Krajewski CR Lombardo R Rao E Ruoslahti DE Bredesen R Pasqualini 1999 Anti-cancer activity of targeted pro-apoptotic peptides Nat Med 5 1032 1038 10470080 10.1038/12469 1:CAS:528:DyaK1MXlslGqtLs%3D (Pubitemid 29439574)
39. G Sithanandam LW Fornwald J Fields LM Anderson 2005 Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549 Oncogene 24 1847 1859 15688028 10.1038/sj.onc.1208381 1:CAS:528:DC%2BD2MXitV2ns7w%3D (Pubitemid 40462787)
40. TG Liu JQ Yin BY Shang Z Min HW He JM Jiang F Chen YS Zhen RG Shao 2004 Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer Cancer Gene Ther 11 748 756 15375377 10.1038/sj.cgt.7700753 1:CAS:528: DC%2BD2cXptlSltL4%3D (Pubitemid 39488473)